絞り込み

16763

広告

「"Baldi GG "[Author]」の検索結果

21件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network.

Pharmacotherapy for liposarcoma: current state of the art and emerging systemic treatments.

Soft tissue sarcoma in Italy: From epidemiological data to clinical networking to improve patient care and outcomes.

Standard treatment and emerging drugs for managing synovial sarcoma: adult's and pediatric oncologist perspective.

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.

Different View on Larynx Preservation Evidence-Based Treatment Recommendations.

Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone.

Complete response after rechallenge with trabectedin in a patient with previously responding high-grade undifferentiated sarcoma.

Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis.

Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.

Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer Network.

Small-bowel neuroendocrine tumor and retroperitoneal fibrosis: efficacy of octreotide and tamoxifen.

Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour.

Bone metastases in soft tissue sarcoma: a survey of natural history, prognostic value and treatment options.

Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients.

Outcome of Second-Line Treatment After First-Line Chemotherapy With the GONO FOLFOXIRI Regimen.

Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: clinical outcome according to KRAS and BRAF mutational status.

Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC).

Refractory neuroendocrine tumor-response to liposomal doxorubicin and capecitabine.

Cigarettes smoking habit may reduce benefit from cetuximab-based treatment in advanced colorectal cancer patients.

  1. 1
  2. 2
Sort by
※並べ替えは表示に時間がかかります